Kenny Walter

3 weeks ago | pharmacypracticenews.com | Kenny Walter

Originally published by our sister publication Pain Medicine NewsBy Kenny WalterSpinal targeted drug delivery (TDD) may be a viable option for pain relief, as a new study shows it could be safer and more effective than long-term opioid use, while increasing patient satisfaction. In the study, a team of researchers conducted a survey to determine whether treatment variables are linked to patient satisfaction at a single pain clinic.

Aug 4, 2024 | biospace.com | Kenny Walter

On Aug. 11, the FDA is expected to make one of the year’s most highly anticipated decisions: whether or not to approve Lykos Therapeutics’ MDMA-assisted treatment for post-traumatic stress disorder. Stakeholders and industry experts recently expressed concern over the therapy, with an advisory committee recommending against its approval. Yet some are still optimistic about its potential—particularly given the continued need for new treatments for post-traumatic stress disorder (PTSD).

Jul 7, 2023 | hcplive.com | Kenny Walter

Jul 7, 2023 | consultantlive.com | Kenny Walter

Jul 7, 2023 | consultantlive.com | Kenny Walter